Skip to Content

Morgan Stanley Pathway Intl Eq TIEUX

Medalist Rating as of | See Morgan Stanley Investment Hub
  • NAV / 1-Day Return 13.48  /  −0.30 %
  • Total Assets 1.2 Bil
  • Adj. Expense Ratio
    0.680%
  • Expense Ratio 0.680%
  • Distribution Fee Level Below Average
  • Share Class Type No Load
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 1.96%
  • Turnover 33%

USD | NAV as of Apr 19, 2024 | 1-Day Return as of Apr 19, 2024, 10:18 PM GMT+0

Morningstar’s Analysis TIEUX

Will TIEUX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Morgan Stanley Pathway Intl Eq earns a Morningstar Medalist Rating of Neutral with strength in areas such as People offset by weaker spots such as Process.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the second-cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings TIEUX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 14.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Us Dollars

3.13 39.2 Mil
Cash and Equivalents

Novo Nordisk A/S Class B

1.97 24.7 Mil
Healthcare

SAP SE

1.80 22.5 Mil
Technology

Roche Holding AG

1.73 21.7 Mil
Healthcare

ASML Holding NV

1.67 21.0 Mil
Technology

Shell PLC

1.42 17.8 Mil
Energy

Novartis AG Registered Shares

1.18 14.8 Mil
Healthcare

AstraZeneca PLC

1.18 14.7 Mil
Healthcare

Nestle SA

1.15 14.4 Mil
Consumer Defensive

Rolls-Royce Holdings PLC

1.14 14.2 Mil
Industrials